List of speakers of the ICPO FORUM 2025
Mariela Agolti
Latin American experience: recent developments
Akram Al-Ibraheem
Navigatingpitfallsin FAPI PET/CT interpretation
Prof. Dr. Richard P. Baum
Present & future of Theranostics applications
Patricia Bautista-Penalosa
Asia-Pacific experience: focuson thePhilippines
Thomas Beyer
Highlights 4th ICPO FORUM
Oliver Buck
Maurits W. Geerlings Award on Ac225
David Cade
Trials and advances in FAP and CAIX
Sergio Calvo
PerspectivefromGE Healthcare
Partha Choudhury
Indian experience: from early patient access to today
Stephanie Combs
Precision medicine benefiting cancer patients
Cathy Cutler
North American experience: from initial market authorization to scaling patient access
Désirée Deandreis
Optimization of workflows and multidisciplinarity
Matthias Eiber
Strength of partnership for new built center
Francesco Giammarile
Class room education, learning with peers and experts
Frederik Giesel
FAP clinical establishment and trials update
Ken Herrmann
Panel discussion for sessions II and III „The critical path to reach 1 million patients“
Rod Hicks
e Education, scaling and standardizing globally
Vicki Jardine
Pb212 clinical opportunity
Hugo Levillain
At211 thanks to accelerate. EU initiative
Lance Lingzhi Hu
AI based PET image reconstruction, lesion classification and quantitation to assist Theranostics decision making
Masha Maharaj
African experience: facts and figures by WARMTH
Josh Mailman
Fundamentals of ethics in Theranostics: a patient perspective
Ana Katrina Mapanao
Tolerability of 161Tb-labeled PSMA ligands in immunocompetent mice
Efrain Perini
Insights on international patient journeys, a session by Oncidium Foundation
Vikas Prasad
Accreditation opportunities at global level
Neil Quigley
Ac225, path towards secure and sustainable supply
Danielle Ralic
AI-powered global radiopharmaceutical trial finder
Mike Sathekge
Space for alpha therapy in oncology arsenal
Pierre-Yves Salaün
European experience: data on the French outpatient landscape
Andrew Scott
Lancet oncology Theranostics: real-world patient benefits
Lalith Shiyam Sundar
ICPO perspective and initiative
Tom Stargardt
Cost-utility analysis of RLT in 2nd and 3rd line treatment for mCRPC in Germany
Wolfgang Weber
GPC3 early data in oncology
Elcin Zan
Maurits W. Geerlings Award on Ac225
Scientific Programme